NEOS

Neos Therapeutics, Inc

NEOS

Nicht mehr börsennotiert

NEOS wurde am 19. März 2021 von der Börse genommen.

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Nantahala Capital Management New Canaan, Connecticut	6,82 Mio. $	–	–	–
2	2 Stonepine Capital Management Bend, Oregon	6,66 Mio. $	-758.565 $	-468.713	-9 %
3	3 Sphera Funds Management Tel Aviv, Israel	5,78 Mio. $	+318.519 $	+196.811	+5 %
4	4 Goldman Sachs New York	3,59 Mio. $	-28.591 $	-17.666	-0,7 %
5	5 Vanguard Group Malvern, Pennsylvania	2,6 Mio. $	-386.802 $	-239.003	-12 %
6	6 BlackRock New York	779.000 $	-6.634 $	-4.099	-0,8 %
7	7 Renaissance Technologies New York	604.000 $	+431.477 $	+266.607	+188 %
8	8 Geode Capital Management Boston, Massachusetts	535.000 $	+8.501 $	+5.253	+1 %
9	9 Deerfield Management New York	475.000 $	–	–	–
10	10 Bridgeway Capital Management Houston, Texas	311.000 $	+113.288 $	+70.000	+50 %
11	PCM 11 Proxima Capital Management New York	305.000 $	–	–	–
12	12 Oxford Asset Management Oxford, United Kingdom	229.000 $	+81.278 $	+50.221	+48 %
13	13 Paloma Partners Greenwich, Connecticut	159.000 $	-171.026 $	-105.676	-50 %
14	14 Northern Trust Chicago, Illinois	158.000 $	-629.418 $	-388.914	-78 %
15	15 Brandywine Global Investment Management Philadelphia, Pennsylvania	141.000 $	–	–	–
16	16 Winton Group London, United Kingdom	132.000 $	+144.154 $	+89.072	Neu
17	WA 17 Wealthstar Advisors Plano, Texas	108.000 $	–	–	–
18	18 Algert Global San Francisco, California	107.000 $	-9.079 $	-5.610	-7 %
19	19 Wells Fargo San Francisco, California	97.000 $	-13.685 $	-8.456	-11 %
20	20 Alambic Investment Management Belvedere, California	94.000 $	-251.915 $	-155.657	-71 %
21	21 Citigroup New York	91.000 $	-2.907 $	-1.796	-3 %
22	22 Millennium Management New York	60.000 $	-654.415 $	-404.359	-91 %
23	23 State Street Boston, Massachusetts	58.000 $	-8.246 $	-5.095	-11 %
24	24 California Public Employees Retirement System Sacramento, California	58.000 $	–	–	–
25	25 Deutsche Bank Frankfurt Am Main Ge, Germany	37.000 $	+9.265 $	+5.725	+29 %

Neos Therapeutics, Inc NEOS

Neos Therapeutics, Inc

NEOS